129 related articles for article (PubMed ID: 2303819)
1. Solubilisation of the 5-hydroxytryptamine3 receptor from pooled rat cortical and hippocampal membranes.
McKernan RM; Quirk K; Jackson RG; Ragan CI
J Neurochem; 1990 Mar; 54(3):924-30. PubMed ID: 2303819
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
[TBL] [Abstract][Full Text] [Related]
3. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical properties of serotonin 5-HT3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells.
Miquel MC; Emerit MB; Bolaños FJ; Schechter LE; Gozlan H; Hamon M
J Neurochem; 1990 Nov; 55(5):1526-36. PubMed ID: 2213008
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes.
Milburn CM; Peroutka SJ
J Neurochem; 1989 Jun; 52(6):1787-92. PubMed ID: 2566650
[TBL] [Abstract][Full Text] [Related]
6. Effects of detergents on binding of 5-hydroxytryptamine3 receptor antagonist [3H]GR65630 to rat cortical membranes.
Inoue A; Tominaga Y; Nishio H; Segawa T; Nakata Y
Neurochem Int; 1993 Jun; 22(6):547-53. PubMed ID: 8513282
[TBL] [Abstract][Full Text] [Related]
7. [3H]zacopride binding to 5-hydroxytryptamine3 sites on partially purified rabbit enteric neuronal membranes.
Gordon JC; Barefoot DS; Sarbin NS; Pinkus LM
J Pharmacol Exp Ther; 1989 Dec; 251(3):962-8. PubMed ID: 2600824
[TBL] [Abstract][Full Text] [Related]
8. Purification of 5-hydroxytryptamine3 receptors from porcine brain.
Fletcher S; Barnes NM
Br J Pharmacol; 1997 Oct; 122(4):655-62. PubMed ID: 9375961
[TBL] [Abstract][Full Text] [Related]
9. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
[TBL] [Abstract][Full Text] [Related]
10. Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.
Barnes JM; Barnes NM; Costall B; Jagger SM; Naylor RJ; Robertson DW; Roe SY
Br J Pharmacol; 1992 Feb; 105(2):500-4. PubMed ID: 1559139
[TBL] [Abstract][Full Text] [Related]
11. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
Barnes NM; Costall B; Naylor RJ
J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of 5-hydroxytryptamine3 receptors in murine brain and ileum using the novel radioligand [3H]RS-42358-197: evidence for receptor heterogeneity.
Bonhaus DW; Wong EH; Stefanich E; Kunysz EA; Eglen RM
J Neurochem; 1993 Nov; 61(5):1927-32. PubMed ID: 8229003
[TBL] [Abstract][Full Text] [Related]
13. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
14. Molecular properties of 5-hydroxytryptamine3 receptor-type binding sites purified from NG108-15 cells.
Boess FG; Lummis SC; Martin IL
J Neurochem; 1992 Nov; 59(5):1692-701. PubMed ID: 1402914
[TBL] [Abstract][Full Text] [Related]
15. Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.
Bolaños FJ; Schechter LE; Miquel MC; Emerit MB; Rumigny JF; Hamon M; Gozlan H
Biochem Pharmacol; 1990 Oct; 40(7):1541-50. PubMed ID: 2222509
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930.
Neijt HC; Karpf A; Schoeffter P; Engel G; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):493-9. PubMed ID: 3412489
[TBL] [Abstract][Full Text] [Related]
17. Molecular size of the 5-HT3 receptor solubilized from NCB 20 cells.
McKernan RM; Biggs CS; Gillard N; Quirk K; Ragan CI
Biochem J; 1990 Aug; 269(3):623-8. PubMed ID: 2390056
[TBL] [Abstract][Full Text] [Related]
18. Improvement of 5-HT3 receptor binding assay: enhancement of specific [3H]quipazine binding with Triton X-100-treated membranes from rat cortex.
Une T; Furukawa K; Komiya M
Jpn J Pharmacol; 1991 Oct; 57(2):197-203. PubMed ID: 1812298
[TBL] [Abstract][Full Text] [Related]
19. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
[TBL] [Abstract][Full Text] [Related]
20. Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes.
Rinken A; Harro J; Engström L; Oreland L
Biochem Pharmacol; 1998 Feb; 55(4):423-31. PubMed ID: 9514076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
